WAVE Life Sciences Ltd (WVE) Stock Price, Chart, News and AI analysis

Q: Who is the CEO of WAVE Life Sciences Ltd?

Dr. Paul Bolno is the President of WAVE Life Sciences Ltd, joining the firm since 2013.

Q: What is the price performance of WVE stock?

The current price of WVE is $15.98, it has increased 0.03% in the last trading day.

Q: What are the primary business themes or industries for WAVE Life Sciences Ltd?

WAVE Life Sciences Ltd belongs to Pharmaceuticals industry and the sector is Health Care

Q: What is WAVE Life Sciences Ltd market cap?

WAVE Life Sciences Ltd's current market cap is $2.6B

Q: Is WAVE Life Sciences Ltd a buy, sell, or hold?

According to wall street analysts, 17 analysts have made analyst ratings for WAVE Life Sciences Ltd, including 6 strong buy, 11 buy, 2 hold, 0 sell, and 6 strong sell

Home

Stock

WVE

WVE Price

WAVE Life Sciences Ltd

$15.97

2.83%

$0.43

At close: Dec 18, 16:00:00 GMT-5

$15.98

0.03%

$0

Post-market: Dec 18, 20:00:00 GMT-5

Overview Forecast Earnings Dividends Financials



Features

AI Copilot for Stock & Crypto

Trading Strategies

Megabrain Investors Picks

Resources

Market

Ask AI About WVE

No Data Yet

Supported by

-2.2%

-4.59%

30D

+98.75%

+111.09%

YTD

+27.84%

-2.2%

-4.59%

30D

+98.75%

+111.09%

YTD

+27.84%

Follow-Up Questions

Who is the CEO of WAVE Life Sciences Ltd?



What is the price performance of WVE stock?



What are the primary business themes or industries for WAVE Life Sciences Ltd?



What is WAVE Life Sciences Ltd market cap?



Is WAVE Life Sciences Ltd a buy, sell, or hold?



Follow-Up Questions

Who is the CEO of WAVE Life Sciences Ltd?



What is the price performance of WVE stock?



What are the primary business themes or industries for WAVE Life Sciences Ltd?



What is WAVE Life Sciences Ltd market cap?



Is WAVE Life Sciences Ltd a buy, sell, or hold?



WAVE Life Sciences Ltd (WVE) Price

WVE Stock Price Chart

Related News

Insiders Inject $550M Into Three Biotechs After Offerings

Biotechs Challenge Lilly's Obesity Drug Dominance

Wave Obesity Drug Data Challenges GLP-1 Dominance

Wave Life Sciences Targets $250M in Share Offering

Vor Biopharma Stock Soars On Telitacicept Data

Wave Obesity Drug Data Spurs 180% Rally, $350M Offering

GLP-1 Drug Demand Fuels Supplier Growth

New Obesity Drug Data Challenges Market Leaders

Follow-Up Questions

Who is the CEO of WAVE Life Sciences Ltd?

What is the price performance of WVE stock?

What are the primary business themes or industries for WAVE Life Sciences Ltd?

What is WAVE Life Sciences Ltd market cap?

Is WAVE Life Sciences Ltd a buy, sell, or hold?

Related News

Insiders Inject $550M Into Three Biotechs After Offerings

Biotechs Challenge Lilly's Obesity Drug Dominance

Wave Obesity Drug Data Challenges GLP-1 Dominance

Wave Life Sciences Targets $250M in Share Offering

Vor Biopharma Stock Soars On Telitacicept Data

Wave Obesity Drug Data Spurs 180% Rally, $350M Offering

GLP-1 Drug Demand Fuels Supplier Growth

New Obesity Drug Data Challenges Market Leaders

Follow-Up Questions

Who is the CEO of WAVE Life Sciences Ltd?

What is the price performance of WVE stock?

What are the primary business themes or industries for WAVE Life Sciences Ltd?

What is WAVE Life Sciences Ltd market cap?

Is WAVE Life Sciences Ltd a buy, sell, or hold?